<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Urologiia</journal-id><journal-title-group><journal-title xml:lang="en">Urologiia</journal-title><trans-title-group xml:lang="ru"><trans-title>Урология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1728-2985</issn><issn publication-format="electronic">2414-9020</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">696543</article-id><article-id pub-id-type="doi">10.18565/urology.2025.5.137-143</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Literature reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Обзоры литературы</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Risks of acute kidney injury with intravascular administration of an iodine-containing contrast agent in patients with acute pyelonephritis</article-title><trans-title-group xml:lang="ru"><trans-title>Риски возникновения острого повреждения почек при внутрисосудистом введении йодсодержащего контрастного вещества при остром пиелонефрите</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2125-4897</contrib-id><name-alternatives><name xml:lang="en"><surname>Pavlov</surname><given-names>Valentin N.</given-names></name><name xml:lang="ru"><surname>Павлов</surname><given-names>Валентин Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>ClinicDoctor of Medical Sciences, Professor, Academician of the Russian Academy of Sciences, Department of Urology and Oncology, Clinic</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, академик РАН, кафедра урологии и онкологии, Клиника</p></bio><email>kagarmanovaxray@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3210-6593</contrib-id><name-alternatives><name xml:lang="en"><surname>Baykov</surname><given-names>Denis E.</given-names></name><name xml:lang="ru"><surname>Байков</surname><given-names>Денис Энверович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Doctor of Medical Sciences, Professor of the Department of General Surgery, Transplantology and Radiation Diagnostics, Clinic</p></bio><bio xml:lang="ru"><p>д.м.н., профессор кафедры общей хирургии, трансплантологии и лучевой диагностики, Клиника</p></bio><email>kagarmanovaxray@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-3878-6989</contrib-id><name-alternatives><name xml:lang="en"><surname>Kagarmanova</surname><given-names>Alfiya S.</given-names></name><name xml:lang="ru"><surname>Кагарманова</surname><given-names>Альфия Шавкатовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>radiologist of the laboratory of radionuclide diagnostics of the Clinic</p></bio><bio xml:lang="ru"><p>врач-рентгенолог лаборатории радионуклидной диагностики Клиники</p></bio><email>kagarmanovaxray@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-8621-3687</contrib-id><name-alternatives><name xml:lang="en"><surname>Itkulov</surname><given-names>Artur F.</given-names></name><name xml:lang="ru"><surname>Иткулов</surname><given-names>Артур Фиргатович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>surgeon, head of the specialized consultative diagnostic center of the Clinic</p></bio><bio xml:lang="ru"><p>врач-хирург, заведующий специализированным консультативно-диагностическим центром Клиники</p></bio><email>kagarmanovaxray@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Federal State Budgetary Educational Institution of Higher Education Bashkir State Medical University Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-11-18" publication-format="electronic"><day>18</day><month>11</month><year>2025</year></pub-date><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>137</fpage><lpage>143</lpage><history><date date-type="received" iso-8601-date="2025-11-18"><day>18</day><month>11</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-11-18"><day>18</day><month>11</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, ООО «Бионика Медиа»</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/1728-2985/article/view/696543">https://journals.eco-vector.com/1728-2985/article/view/696543</self-uri><abstract xml:lang="en"><p>The occurrence of acute kidney damage associated with the introduction of an iodine-containing contrast agent into the vascular bed, which leads to transient or persistent structural and functional changes in nephrons, endothelial cells, and renal tubule epithelium, is an urgent problem in modern instrumental diagnostics of various pathological processes, since iodine-containing preparations have a strong advantage over «native» scanning. A researcher who uses different techniques depending on the tasks set opens up great prospects in studying many aspects of the structure and function of tissues. New technologies are being actively introduced into clinical practice, with the possibility of selective visualization of small visceral vessels not only using subtractive angiography, but also selective CT angiography/venography. In foreign and domestic literature, the main emphasis is placed on the development of acute kidney damage when using iodine-containing contrast agents in «compromised» patients with chronic structural disorders in the kidneys, with evidence that the risks of acute damage are high in chronic renal failure. As for acute disorders – in some cases with complicated forms of pyelonephritis, life-threatening situations, CT with contrast enhancement and alternative methods of selectiveойangiographyand renal arteries in combination treatmentis extremely necessary.</p></abstract><trans-abstract xml:lang="ru"><p>Возникновение острого повреждения почек, связанного с введением в сосудистое русло йодсодержащего контрастного вещества, приводящего к преходящим либо стойким структурным и функциональным изменениям в нефронах, эндотелиальных клетках, эпителии почечных канальцев, является актуальной проблемой в современной инструментальной диагностике различных патологических процессов, поскольку йодсодержащие препараты обладают сильным преимуществом в сравнении с «нативным» сканированием. Исследователю, использующему различные методики в зависимости от поставленных задач, открываются большие перспективы в изучении множества аспектов структуры и функции тканей. В клиническую практику активно внедряются новые технологии с возможностью селективной визуализации мелких висцеральных сосудов, применяя не только субтракционную ангиографию, но также и селективную компьютерную томографию (КТ)-ангиографию/-венографию. В зарубежной и отечественной литературе основной упор сделан на развитии острого повреждения почек при применении йодсодержащих контрастных препаратов именно у «скомпрометированных» пациентов, имеющих хронические структурные нарушения в почках, с доказательной базой, что при хронической почечной недостаточности риски острого повреждения велики. Что касается острых нарушений – в некоторых случаях при осложненных формах пиелонефрита, жизнеугрожающих ситуациях, проведение КТ с контрастным усилением и альтернативных методик селективной ангиографии почечных артерий в комбинированном лечении, бывает крайне необходимым.</p></trans-abstract><kwd-group xml:lang="en"><kwd>selective angiography of the renal arteries</kwd><kwd>CT angiography of the renal arteries</kwd><kwd>post-contrast acute kidney injury</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>селективная ангиография почечных артерий</kwd><kwd>КТ-ангиография почечных артерий</kwd><kwd>постконтрастное острое повреждение почек</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Nicola R, Menias CO. Urinary Obstruction, Stone Disease, and Infection. In: Hodler J, Kubik-Huch RA, von Schulthess GK, eds. Diseases of the Abdomen and Pelvis 2018-2021: Diagnostic Imaging - IDKD Book. Cham (CH): Springer; March 21, 2018.223–228.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Boccatonda A, Stupia R, Serra C. Ultrasound, contrast-enhanced ultrasound and pyelonephritis: A narrative review. World J Nephrol. 2024;13(3):98300. doi:10.5527/wjn.v13.i3.98300</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Клинические рекомендации европейской ассоциации урологов по инфекциям в урологии, под ред. G. Bonkat (председатель), R. Bartoletti, F. Bruyère, T. Cai, S.E. Geerlings, B. Köves, J. Kranz, S. Schubert, A. Pilatz, R. Veeratterapillay, F. Wagenlehner, 2024 г.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Bedayat A, Hassani C, Prosper AE, Chalian H, Khoshpouri P, Ruehm SG. Recent Innovations in Renal Vascular Imaging. Radiol Clin North Am. 2020;58(4):781-796. doi:10.1016/j.rcl.2020.02.010</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Gaudiano C, Tadolini M, Busato F et al. Multidetector CT urography in urogenital tuberculosis: use of reformatted images for the assessment of the radiological findings. A pictorial essay. Abdom Radiol (NY). 2017;42(9):2314-2324. doi:10.1007/s00261-017-1129-0</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Schöckel L, Jost G, Seidensticker P, Lengsfeld P, Palkowitsch P, Pietsch H (2020) Developments in X-Ray contrast media and the potential impact on computed tomography. Invest Radiol 55(9):592–597.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Narroway HG, Kovacic JL, Bourke BM, Louis-Johnsun M, Latif ER, Bourke VC. Selective Angioembolisation of Iatrogenic Renal Artery Pseudoaneurysms Following Minimally Invasive Urological Procedures: A Single Centre Case Series. Vasc Endovascular Surg. Published online June 9, 2022. doi:10.1177/15385744221108041</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Zeng H, Xie JY, Xu LX, Cao WY, Liu MJ, Que SW. Comparative study of the clinical value of digital subtraction angiography via femoral and radial arterial paths. Am J Transl Res. 2024;16(7):3064-3071. Published 2024 Jul 15. doi:10.62347/UBEV9768</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Hafiani H, Charif Saibari R, Morsad N, Rami A. Sven Ivar Seldinger (1921-1998): The Founding Father of Interventional Radiology. Cureus. 2024;16(5):e60397. Published 2024 May 16. doi:10.7759/cureus.60397</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Foster RS, Shuford WH, Weens HS. Selective renal arteriography in medical diseases of the kidney. Am J Roentgenol Radium Ther Nucl Med. 1965;95(2):291-308. doi:10.2214/ajr.95.2.291</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Glybochko P.V. et al. The Role of Radiation Diagnostic Methods in the Development of Urology. Russian Electronic Journal of Radiation Diagnostics. 2011;1(4):5–11. Russian (Глыбочко П.В. и др. Роль лучевых методов диагностики в становлении урологии. Российский электронный журнал лучевой диагностики. 2011;1(4):5–11).</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Garcarek J, Kurcz J, Guziński M, Banasik M, Miś M, Gołębiowski T. Intraarterial CT Angiography Using Ultra Low Volume of Iodine Contrast - Own Experiences. Pol J Radiol. 2015;80:344–349. Published 2015 Jul 5. doi:10.12659/PJR.894050</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Szczurowska A, Banasik M, Kurcz J et al. Intra-arterial computed tomography angiography with ultra-low volume of iodine contrast and stent implantation in transplant renal artery stenosis in terms of contrast-induced kidney injury – a preliminary report. Pol J Radiol. 2020;85:e174-e177. Published 2020 Apr 3. doi:10.5114/pjr.2020.94364</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>van der Molen, A.J., Reimer, P., Dekkers, I.A. et al. Post-contrast acute kidney injury – Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors. Eur Radiol. 2018;28:2845–2855. https://doi.org/10.1007/s00330-017-5246-5</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>van der Molen AJ, Reimer P, Dekkers IA et al. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2018;28(7):2856–2869. doi:10.1007/s00330-017-5247-4</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Cho E, Ko GJ. The Pathophysiology and the Management of Radiocontrast-Induced Nephropathy. Diagnostics (Basel). 2022;12(1):180. Published 2022 Jan 12. doi:10.3390/diagnostics12010180</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>de Laforcade L, Bobot M, Bellin MF et al. Kidney and contrast media: Common viewpoint of the French Nephrology societies (SFNDT, FIRN, CJN) and the French Radiological Society (SFR) following ESUR guidelines. Diagn Interv Imaging. 2021;102(3):131–139. doi:10.1016/j.diii.2021.01.007</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Kusirisin P, Chattipakorn SC, Chattipakorn N. Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches. J Transl Med. 2020;18(1):400. Published 2020 Oct 20. doi:10.1186/s12967-020-02574-8</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Davenport MS, Perazella MA, Yee J et al. Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Radiology. 2020;294(3):660–668. doi:10.1148/radiol.2019192094</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Isaka Y, Hayashi H, Aonuma K, Japanese Society of Nephrology, Japan Radiological Society, Japanese Circulation Society Joint Working Group et al. Guideline on the use of iodinated contrast media in patients with kidney disease 2018. Jpn J Radiol. 2020;38(1):3–46.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314. doi:10.1016/j.kint.2023.10.018</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Aylward R, Casula A, Tiffin N, et al. Consistency of alerts generated by, and implementation of, the NHS England acute kidney injury detection algorithm in English laboratories. J Nephrol. 2024;37(8):2317–2325. doi:10.1007/s40620-024-02030-6</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>de Laforcade L, Bobot M, Bellin MF et al. Kidney and contrast media: Common viewpoint of the French Nephrology societies (SFNDT, FIRN, CJN) and the French Radiological Society (SFR) following ESUR guidelines. Diagn Interv Imaging. 2021;102(3):131–139. doi:10.1016/j.diii.2021.01.007</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Castro I, Relvas M, Gameiro J, Lopes JA, Monteiro-Soares M, Coentrão L. The impact of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury on mortality and clinical outcomes: a meta-analysis. Clin Kidney J. 2022;15(10):1932–1945. doi:10.1093/ckj/sfac139</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Yoon SY, Kim JS, Jeong KH, Kim SK. Acute Kidney Injury: Biomarker-Guided Diagnosis and Management. Medicina (Kaunas). 2022;58(3):340. doi:10.3390/medicina58030340</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>The National Institute for Health and Care Excellence [NICE]. Acute kidney injury; Prevention, detection and management up to the point of renal replacement therapy (Nice Guideline 169). London: Royal College of Physicians (2019).</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Dong G, Qin J, An Y et al. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020;32(3):313–318. doi:10.3760/cma.j.cn121430-20200218-00192</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Huynh K, Baghdanian AH, Baghdanian AA, Sun DS, Kolli KP, Zagoria RJ. Updated guidelines for intravenous contrast use for CT and MRI. Emerg Radiol. 2020;27(2):115–126] [Quality Control and Safety Management Committee of Chinese Society of Radiology Chinese Medical Association. Expert consensus of iodinated contrast agent use in patients with renal diseases. Chin J Radiol. 2021;55(6):580–590 (Article in Chinese)</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Chinese Society of Clinical Pharmacy, Hospital Pharmacy Professional Committee of Chinese Pharmaceutical Association, Chinese Society of Nephrology. Expert consensus on prevention and treatment of iodine contrast media-induced acute kidney injury. Chin J Nephrol. 2022;38(3):265–288 (Article in Chinese)</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Orlacchio A, Guastoni C, Beretta GD et al. SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations-consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM). Radiol Med. 2022;127(5):534–542.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Volgina G.V., Kozlovskaya N.L., Shchekochikhin D.Yu. Clinical Guidelines for the Prevention, Diagnosis, and Treatment of Contrast-Induced Nephropathy / Scientific Society of Nephrologists of Russia. Moscow, 2013. 18 p. Russian (Волгина Г.В., Козловская Н.Л., Щекочихин Д.Ю. Клинические рекомендации по профилактике, диагностике и лечению контраст-индуцированной нефропатии / Научное общество нефрологов России. М., 2013. 18 с.).</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Shan Y, Lin M, Gu F, et al. Association between fasting stress hyperglycemia ratio and contrast-induced acute kidney injury in coronary angiography patients: a cross-sectional study. Front Endocrinol (Lausanne). 2023;14:1300373. Published 2023 Dec 13. doi:10.3389/fendo.2023.1300373</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Zebrauskaite A, Ziubryte G, Mackus L, et al. A Simple Strategy to Reduce Contrast Media Use and Risk of Contrast-Induced Renal Injury during PCI: Introduction of an «Optimal Contrast Volume Protocol» to Daily Clinical Practice. J Cardiovasc Dev Dis. 2023;10(9):402. doi:10.3390/jcdd10090402</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Chen Z, Li D, Lin M et al. Association of Hemoglobin Glycation Index With Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Retrospective Study. Front Physiol. 2022;13:870694. doi:10.3389/fphys.2022.870694</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Kusirisin P, Chattipakorn SC, Chattipakorn N. Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches. J Transl Med. 2020;18:400. https://doi.org/10.1186/s12967-020-02574-8</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Stratta P, Quaglia M, Airoldi A, Aime S. Structure-function relationships of iodinated contrast media and risk of nephrotoxicity. Curr Med Chem. 2012;19(5):736–743. doi:10.2174/092986712798992084</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Macdonald DB, Hurrell CD, Costa AF et al. Canadian Association of Radiologists Guidance on Contrast-Associated Acute Kidney Injury. Can J Kidney Health Dis. 2022;9:20543581221097455. doi:10.1177/20543581221097455</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>McDonald JS, McDonald RJ, Comin J, Williamson EE, Katzberg RW, Murad MH et al. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology. 2013;267:119–28.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>McDonald JS, Larson NB, Schmitz JJ et al. Acute Adverse Events After Iodinated Contrast Agent Administration of 359,977 Injections: A Single-Center Retrospective Study. Mayo Clin Proc. 2023;98(12):1820–1830. doi:10.1016/j.mayocp.2023.02.032</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>McDonald JS. Selecting an Alternative Contrast Agent to Prevent Repeat Allergic-like Reactions. Radiology. 2023;309(1):e231979. doi:10.1148/radiol.231979</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>McDonald JS, McDonald RJ. Risk of Acute Kidney Injury Following IV Iodinated Contrast Media Exposure: 2023 Update, From the AJR Special Series on Contrast Media. AJR Am J Roentgenol. 2024;223(1):e2330037. doi:10.2214/AJR.23.30037</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>McDonald RJ, McDonald JS. Iodinated Contrast and Nephropathy: Does It Exist and What Is the Actual Evidence? Radiol Clin North Am. 2024;62(6):959–969. doi:10.1016/j.rcl.2024.03.001</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Pohlan J, Witham D, Farkic L et al. Body computed tomography in sepsis: predictors of CT findings and patient outcomes in a retrospective medical ICU cohort study. Emerg Radiol. 2022;29(6):979–985. doi:10.1007/s10140-022-02083-9</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Gorelik Y, Bloch-Isenberg N, Yaseen H, Heyman SN, Khamaisi M. Acute Kidney Injury After Radiocontrast-Enhanced Computerized Tomography in Hospitalized Patients With Advanced Renal Failure: A Propensity-Score-Matching Analysis. Invest Radiol. 2020;55(10):677–687. doi:10.1097/RLI.0000000000000659</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Graversen HV, Nørgaard M, Nitsch D, Christiansen CF. Preadmission kidney function and risk of acute kidney injury in patients hospitalized with acute pyelonephritis: A Danish population-based cohort study. PLoS One. 2021;16(3):e0247687. Published 2021 Mar 3. doi:10.1371/journal.pone.0247687</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Jeon DH, Jang HN, Cho HS, et al. Incidence, risk factors, and clinical outcomes of acute kidney injury associated with acute pyelonephritis in patients attending a tertiary care referral center. Ren Fail. 2019;41(1):204–210. doi:10.1080/0886022X.2019.1591995</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Dzgoeva F.U., Remizov O.V. Post-Contrast acute kidney injury. Recommendations for updated of the European Society of Urogenital Radiology Contrast Medium Safety Committee guidelines (2018). Part 1. Nephrology (Saint-Petersburg). 2019;23(3):10-20. (In Russ.) https://doi.org/10.24884/1561-6274-2019-23-3-10-20</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Clement O, Romanini L, van der Molen AJ; On behalf ESUR Contrast Media Safety Committee. Contrast media safety: update on recent ESUR-Contrast Media Safety Committee publications. Eur Radiol. 2024;34(11):7208–7210. doi:10.1007/s00330-024-10725-4</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Li Y, Wang J. Contrast-induced acute kidney injury: a review of definition, pathogenesis, risk factors, prevention and treatment. BMC Nephrol. 2024;25(1):140. doi:10.1186/s12882-024-03570-6</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Yin W, Zhou G, Zhou L et al (2020) Validation of pre-operative risk scores of contrast-induced acute kidney injury in a Chinese cohort. BMC Nephrol 21(1):45.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Interventional Cardiology Group, Chinese Society of Cardiology, Chinese Medical Association; Macrovascular Group, Chinese Society of Cardiology, Chinese Medical Association; Editorial Board of Chinese Journal of Cardiology. Zhonghua Xin Xue Guan Bing Za Zhi. 2021;49(10):972–985. doi:10.3760/cma.j.cn112148-20210315-00224</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Serif L, Chalikias G, Didagelos M et al. Application of 17 contrast-induced acute kidney injury risk prediction models. Cardiorenal Med. 2020;10(3):162–174.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Williams L-MS, Walker GR, Loewenherz JW, Gidel LT. Association of contrast and acute kidney injury in the critically ill: a propensity-matched study. Chest. 2020;157:866–76.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Wilhelm-Leen E, Montez-Rath ME, Chertow G. Estimating the Risk of Radiocontrast-Associated Nephropathy. J Am Soc Nephrol. 2017;28(2):653–659. doi:10.1681/ASN.2016010021</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Lopatkin, N.A. Angiography in Urology. Moscow: Meditsina, 1968. 271 p. Russian (Лопаткин Н.А. Ангиография в урологии. М.: Медицина, 1968. 271 с.).</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Angiology and Vascular Surgery: Official Journal of the Russian Society of Angiologists and Vascular Surgeons: Issues for 2024. 2024;30(2):150. Russian (Ангиология и сосудистая хирургия: официальный журнал Российского общества ангиологов и сосудистых хирургов: Выпуски за 2024 г. 2024;30(2):150).</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Hariri G, Collet L, Duarte L et al. Prevention of cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis of non-pharmacological interventions. Crit Care. 2023;27(1):354. doi:10.1186/s13054-023-04640-1</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Leballo G, Moutlana HJ, Muteba MK, Chakane PM. Factors associated with acute kidney injury and mortality during cardiac surgery. Cardiovasc J Afr. 2021;32(6):308–313. doi:10.5830/CVJA-2020-063</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Pérez-Fernández X, Ulsamer A, Cámara-Rosell M et al. Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery: The SIRAKI02 Randomized Clinical Trial. JAMA. 2024;332(17):1446–1454. doi:10.1001/jama.2024.20630</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Nyman U, Almén T, Jacobsson B, Aspelin P (2012) Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections? Eur Radiol 22:1366–1371.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Mehran R, Aymong ED, Nikolsky E et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393–99. http://www.esur.org/Nephrogenic_Fibrosis.39.0.html</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Kooiman J, Le Haen PA, Gezgin G et al. Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design. Am Heart J. 2013;165:793–799.</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Tong GE, Kumar S, Chong KC et al. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration. Abdom Radiol. 2016;41:91–99.</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Sharma A, Kilari S, Cai C, Simeon ML, Misra S. Increased fibrotic signaling in a murine model for intra-arterial contrast-induced acute kidney injury. Am J Physiol Renal Physiol. 2020;318(5):F1210-F1219. doi:10.1152/ajprenal.00004.2020</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Prasad A, Ortiz-Lopez C, Khan A, Levin D, Kaye DM. Acute kidney injury following peripheral angiography and endovascular therapy: a systematic review of the literature. Catheter Cardiovasc Interv. 2016;88:264–273.</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Lee SR, Zhuo H, Zhang Y, Dahl N, Dardik A, Ochoa Chaar CI. Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions. J Vasc Surg. 2020;72(2):603-610.e1. doi:10.1016/j.jvs.2019.09.059</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Nie Z, Liu Y, Wang C, Sun G, Chen G, Lu Z. Safe Limits of Contrast Media for Contrast-Induced Nephropathy: A Multicenter Prospective Cohort Study. Front Med (Lausanne). 2021;8:701062. doi:10.3389/fmed.2021.701062</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Ilaria G, Kianoush K, Ruxandra B et al. Clinical adoption of Nephrocheck® in the early detection of acute kidney injury. Ann Clin Biochem. 2021;58(1):6-15. doi:10.1177/0004563220970032</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Gallo GS, Caruso C, Iannazzo E et al. Feasibility of Ultra-Low Volume Contrast-Saline Mixture Injection With Dual-Flow Technique in a Pre-TAVI Computed Tomography Angiography. Heart Lung Circ. 2023;32(4):525-534. doi:10.1016/j.hlc.2022.12.013</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Wen Y, Parikh CR. Current concepts and advances in biomarkers of acute kidney injury. Crit Rev Clin Lab Sci. 2021;58(5):354-368. doi:10.1080/10408363.2021.1879000</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Sun Q, Kang Z, Li Z, Xun M. Urinary NGAL, IGFBP-7, and TIMP-2: novel biomarkers to predict contrast medium-induced acute kidney injury in children. Ren Fail. (2022) 44:1201–6. doi: 10.1080/0886022X.2022.2075277</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Yoon SY, Kim JS, Jeong KH, Kim SK. Acute Kidney Injury: Biomarker-Guided Diagnosis and Management. Medicina (Kaunas). 2022;58(3):340. doi:10.3390/medicina58030340</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Murugan R, Boudreaux-Kelly MY, Kellum JA, Palevsky PM, Weisbord S; Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON) Study Investigators. Kidney Cell Cycle Arrest and Cardiac Biomarkers and Acute Kidney Injury Following Angiography: The Prevention of Serious Adverse Events Following Angiography (PRESERVE) Study. Kidney Med. 2022;5(3):100592. doi:10.1016/j.xkme.2022.100592</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Toruan M, Pranata R, Setianto B, Haryana S. The role of microRNA in contrast-induced nephropathy: a scoping review and meta-analysis. Biomed Res Int. 2020:1–6. doi: 10.1155/2020/4189621.</mixed-citation></ref></ref-list></back></article>
